- 2025-09-26 11:02Gefitinib N-oxide hydrochloride
- 2025-09-26 11:02CC-90003 1621999-82-3
- 2025-09-26 11:02Gefitinib impurity 2 (gefitinib impurity 1) 246512-44-7
- 2025-09-26 11:02BAY885 2307249-33-6
- 2025-09-26 11:02FIIN-3 1637735-84-2
- 2025-09-26 11:02AZD-0364 2097416-76-5
- 2025-09-26 11:02ErbB-2-binding peptide (HER2-binding peptide) 562791-56-4
- 2025-09-26 11:02AX15836 2035509-96-5
- 2025-09-26 11:02Epitinib succinate (HMPL-813 succinate) 2252334-12-4
- 2025-09-26 11:02ASTX029 2095719-92-7
- 2025-09-26 11:02Epitinib (HMPL-813) 1203902-67-3
- 2025-09-26 11:02ASN007 2055597-12-9
- 2025-09-26 11:02Epidermal Growth Factor Receptor Peptide (985-996) 96249-43-3
- 2025-09-26 11:02ASN-007 benzenesulfonate 2055597-39-0
- 2025-09-26 11:02Epidermal growth factor (EGF) (phosphate)
- 2025-09-26 11:02Anticancer agent 231 128519-30-2
- 2025-09-26 11:02EMI56 2414374-41-5
- 2025-09-26 11:02Ambuic acid 340774-69-8
- 2025-09-26 11:02EMI48 34564-13-1
- 2025-09-26 11:02AG126 118409-62-4
